alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,051–7,075 of 7,816 matching trials · page 283 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Safety Study of Dabigatran in CADASIL
NCT01361763
Dabigatran; Antiplatelets
Runs in: Italy · 2 sites 		PHASE2
other		 UNKNOWN 50 S. Andrea Hospital
OTHER		 2014-02-11
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
NCT00423085
Rivastigmine transdermal patch; Placebo
Runs in: Japan · 1 site 		PHASE3
symptomatic-cholinergic		 COMPLETED 859 Novartis Pharmaceuticals
INDUSTRY		 2014-02-10
Creatine Safety and Tolerability in Premanifest HD: PRECREST
NCT00592995
Creatine monohydrate; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 64 Massachusetts General Hospital
OTHER		 2014-02-10
Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
NCT01411150
Creatine Monohydrate
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 38 Massachusetts General Hospital
OTHER		 2014-02-10
Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
NCT01411163
Creatine monohydrate
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 24 Massachusetts General Hospital
OTHER		 2014-02-10
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)
NCT01421056
CHF 5074 1x; CHF 5074 2x; CHF 5074 3x
Runs in: Italy; United States · 6 sites 		PHASE2
other		 COMPLETED 74 Chiesi Farmaceutici S.p.A.
INDUSTRY		 2014-02-06
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase
NCT01602393
CHF 5074 1x; CHF 5074 2x; CHF 5074 3x
Runs in: Italy; United States · 5 sites 		PHASE2
other		 COMPLETED 51 Chiesi Farmaceutici S.p.A.
INDUSTRY		 2014-02-06
Agitation in Post Operative Neurosurgical Patients
NCT00590499
Runs in: China · 1 site 		NA
other		 COMPLETED 120 Capital Medical University
OTHER		 2014-01-31
Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?
NCT02051244
Runs in: Israel · 1 site 		NA
other		 UNKNOWN 60 Carmel Medical Center
OTHER		 2014-01-31
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161
memantine
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 12 Northwell Health
OTHER		 2014-01-28
Effect of Repetitive Transcranial Magnetic Stimulation on Language in Alzheimer's Disease
NCT00814697
Repetitive Transcranial Magnetic Coil Stimulation (rTMS)
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 12 The New York Memory Services
OTHER		 2014-01-28
Nutritional Programme for Dementia Elderly Patient
NCT00479843
Nutritional programme
Runs in: Spain · 1 site 		NA
other		 COMPLETED 946 Société des Produits Nestlé (SPN)
INDUSTRY		 2014-01-24
Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images
NCT01672827
[18F]Flutemetamol 		PHASE3
other		 COMPLETED 276 GE Healthcare
INDUSTRY		 2014-01-24
Delta-THC in Behavioral Disturbances in Dementia
NCT01302340
Delta-THC; placebo; Delta-THC
Runs in: Netherlands · 2 sites 		PHASE2
other		 COMPLETED 22 Radboud University Medical Center
OTHER		 2014-01-22
The Detection of Early Dementia With the Digital Game Memory
NCT02041728
Runs in: Belgium · 1 site 		NA
other		 COMPLETED 20 Universitaire Ziekenhuizen KU Leuven
OTHER		 2014-01-22
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
NCT00718770
Bexarotene
Runs in: United States · 1 site 		EARLY_PHASE1
other		 COMPLETED 10 University of Colorado, Denver
OTHER		 2014-01-17
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
NCT00934375
Aricept (donepezil hydrochloride); placebo
Runs in: United States · 49 sites 		PHASE4
symptomatic-cholinergic		 COMPLETED 145 Eisai Inc.
INDUSTRY		 2014-01-14
Long-term Outcome of General Anesthesia on Dysgnosia
NCT01184638
Sevoflurane; Propofol
Runs in: China · 1 site 		PHASE4
other		 UNKNOWN 10,000 Nanjing Medical University
OTHER		 2014-01-14
New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study
NCT01773915
Runs in: Belgium · 1 site 		NA
other		 UNKNOWN 20 Universitaire Ziekenhuizen KU Leuven
OTHER		 2014-01-14
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants
NCT01887535
JNJ-54861911 3 mg; JNJ-54861911 10 mg; JNJ-54861911 30 mg; JNJ-5486...
Runs in: Belgium · 1 site 		PHASE1
other		 COMPLETED 70 Janssen Research & Development, LLC
INDUSTRY		 2014-01-14
Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease
NCT01661673
EVP-0962; Placebo
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 52 FORUM Pharmaceuticals Inc
INDUSTRY		 2014-01-13
Efficacy of Early Stage Alzheimer's Support Groups
NCT00391794
Early Stage Memory Loss Support Group; Educational Seminar
Runs in: United States · 1 site 		NA
other		 COMPLETED 154 University of Washington
OTHER		 2014-01-10
Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease
NCT01481558
Transcranial direct current stimulation
Runs in: Brazil · 1 site 		PHASE2
other		 COMPLETED 40 University of Sao Paulo
OTHER		 2014-01-09
A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients
NCT00996918
Bapineuzumab 0.5 mg/kg; Bapineuzumab 1.0 m/kg
Runs in: Australia; Belgium; Chile; Finland; France; Italy; Japan;... · 82 sites 		PHASE3
anti-amyloid-antibody		 TERMINATED 198 Pfizer
INDUSTRY		 2014-01-01
Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study
NCT02018913 		NA
other		 UNKNOWN 140 Maastricht University Medical Center
OTHER		 2013-12-23

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →